Testing effectiveness (Phase 2)Study completedNCT01058434
What this trial is testing
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
Who this might be right for
Relapsed or Refractory Multiple Myeloma
Novartis Pharmaceuticals 43